Sandra Dunn
7Patents
2h-index
13Co-inventors
40Inventor score
Filing activity: Jan 22, 2013 → Feb 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9771366B2 | Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9687466B2 | Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme | Emerging Cross-Sectional Technologies | 4 | Active |
| US10081632B2 | Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10758530B2 | Carboxamide derivatives useful as rsk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10201521B2 | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma | Emerging Cross-Sectional Technologies | 1 | Active |
| US11234955B2 | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma | Emerging Cross-Sectional Technologies | 0 | Active |
| US12378245B2 | Crystalline forms of an RSK inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.